|

industry news and legislative updates
BRIAN BERMAN, MD NAMED RECIPIENT OF $100,000 BRAVEWELL LEADERSHIP
AWARD FOR INTEGRATIVE MEDICINE
Dr. Brian
Berman, one of the leading physicians in America to champion the
growth of integrative medicine, was named by the Bravewell
Collaborative as recipient of the 2005 Bravewell Leadership Award.
Dr. Berman is founder and director of the Center for Integrative
Medicine at the University of Maryland School of Medicine, which was
the first clinic of its kind in the nation. He has dedicated his
career to the expansion of evidence-based integrative care and is
acclaimed for both his groundbreaking research studies, as well as his
patient-centered treatment that focuses on the whole person – mind,
body and spirit.
Dr. Berman is
particularly noted for his landmark research study, published in the
Annals of Internal Medicine in December 2004, which
proved acupuncture is a safe and effective therapy in the treatment of
arthritis. The study, one of the largest clinical trials of
acupuncture ever done, is considered a model for how scientific
testing can evaluate alternative therapies. In October 2005, the
National Center for Complementary and Alternative Medicine (NCCAM)
announced a $10 million grant to Dr. Berman to conduct additional
evidence-based investigation to advance the understanding of the
potential benefits and underlying mechanism of ancient Chinese
medicine including acupuncture and herbal treatments.
A
bio and photograph of Dr. Berman receiving the award available at:
www.bravewell.org/press
ITraditional
medicines congress calls for comments on "ideal Regulatory model"
Nine national
organizations working together as the Traditional Medicines (TM)
Congress* have released the first public draft of " A Proposed
Regulatory Model for Traditional Medicines: Guiding Assumptions and
Key Components." This comprehensive document presents ideas for
a new model for the regulation of traditional medicines in the
United States, and will now be subject to an open review process by
interested individuals and organizations.
The Medicinal Herb
Consortium (MHC) joined with eight other organizations in the spring
of 2004 to exchange ideas about the future of traditional medicines in
the U.S. The result of these discussions was the formation of the TM
Congress. In seeking to emphasize both the value of traditional
medicines and the responsibilities that are associated with their use,
it was agreed that:
The goal of the Traditional Medicines Congress is to benefit public
health by ensuring access to traditional medicines in a manner that
provides a reasonable expectation of public safety.
"We are pleased to
join forces with herbal practitioners and product makers in this
effort to address one of the most critical issues affecting use of
medicinal herbs," said Jean Giblette, MHC delegate to the TM Congress
along with Leslie Gardner of the Sonoma County Herb Exchange. The
MHC considers the proposed model advantageous in that, while the
current dietary supplement law would not be changed, recognition of
Traditional Medicines as a new, distinct category could help win
greater appreciation for farmers' ecologically-grown and responsibly
wild-harvested products.
Anyone with an
interest in traditional medicines is now invited to review the draft
document that the TM Congress has developed. A Proposed
Regulatory Model for Traditional Medicines is posted online at:
http://www.ahpa.org/05_1129_TMCongress_ProposedModel.pdf
Comments can be
emailed to
TMCongressFeedback@pobox.com. The deadline for comments is March
31, 2006.
*Acupuncture and
Oriental Medicine Alliance (AOMA); American Association of
Naturopathic Physicians (AANP); American Association of Oriental
Medicine (AAOM); American Herbalist Guild (AHG); American Herbal
Products Association (AHPA); Council of Colleges of Acupuncture and
Oriental Medicine (CCAOM); Medicinal Herb Consortium (MHC); National
Ayurvedic Medical Association (NAMA); and National Certification
Commission for Acupuncture and Oriental Medicine (NCCAOM).

|